Sign In
Buy CMPR
Cimpress N.V Earnings Calls
| Release date | Apr 29, 2026 |
| EPS estimate | $0.150 |
| EPS actual | $0.550 |
| EPS Surprise | 266.67% |
| Revenue estimate | 858.8M |
| Revenue actual | 886.209M |
| Revenue Surprise | 3.19% |
| Release date | Jan 28, 2026 |
| EPS estimate | $1.61 |
| EPS actual | $1.95 |
| EPS Surprise | 21.12% |
| Revenue estimate | 993.749M |
| Revenue actual | 1.042B |
| Revenue Surprise | 4.88% |
| Release date | Oct 29, 2025 |
| EPS estimate | $0.290 |
| EPS actual | $0.300 |
| EPS Surprise | 3.45% |
| Revenue estimate | 993.415M |
| Revenue actual | 863.277M |
| Revenue Surprise | -13.10% |
| Release date | Jul 29, 2025 |
| EPS estimate | $0.97 |
| EPS actual | -$1.02 |
| EPS Surprise | -205.15% |
| Revenue estimate | 844.244M |
| Revenue actual | 869.483M |
| Revenue Surprise | 2.99% |
Last 4 Quarters for Cimpress N.V
Below you can see how CMPR performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 29, 2025 |
| Price on release | $49.72 |
| EPS estimate | $0.97 |
| EPS actual | -$1.02 |
| EPS surprise | -205.15% |
| Date | Price |
|---|---|
| Jul 23, 2025 | $48.79 |
| Jul 24, 2025 | $48.47 |
| Jul 25, 2025 | $48.46 |
| Jul 28, 2025 | $49.57 |
| Jul 29, 2025 | $49.72 |
| Jul 30, 2025 | $55.74 |
| Jul 31, 2025 | $55.31 |
| Aug 01, 2025 | $53.19 |
| Aug 04, 2025 | $53.88 |
| 4 days before | 1.91% |
| 4 days after | 8.37% |
| On release day | 12.11% |
| Change in period | 10.43% |
| Release date | Oct 29, 2025 |
| Price on release | $66.75 |
| EPS estimate | $0.290 |
| EPS actual | $0.300 |
| EPS surprise | 3.45% |
| Date | Price |
|---|---|
| Oct 23, 2025 | $66.29 |
| Oct 24, 2025 | $67.35 |
| Oct 27, 2025 | $65.45 |
| Oct 28, 2025 | $66.72 |
| Oct 29, 2025 | $66.75 |
| Oct 30, 2025 | $74.19 |
| Oct 31, 2025 | $69.21 |
| Nov 03, 2025 | $68.12 |
| Nov 04, 2025 | $66.09 |
| 4 days before | 0.694% |
| 4 days after | -0.99% |
| On release day | 11.15% |
| Change in period | -0.302% |
| Release date | Jan 28, 2026 |
| Price on release | $77.91 |
| EPS estimate | $1.61 |
| EPS actual | $1.95 |
| EPS surprise | 21.12% |
| Date | Price |
|---|---|
| Jan 22, 2026 | $80.66 |
| Jan 23, 2026 | $78.85 |
| Jan 26, 2026 | $78.63 |
| Jan 27, 2026 | $78.53 |
| Jan 28, 2026 | $77.91 |
| Jan 29, 2026 | $78.01 |
| Jan 30, 2026 | $79.09 |
| Feb 02, 2026 | $80.54 |
| Feb 03, 2026 | $76.61 |
| 4 days before | -3.41% |
| 4 days after | -1.67% |
| On release day | 0.128% |
| Change in period | -5.02% |
| Release date | Apr 29, 2026 |
| Price on release | $81.42 |
| EPS estimate | $0.150 |
| EPS actual | $0.550 |
| EPS surprise | 266.67% |
| Date | Price |
|---|---|
| Apr 23, 2026 | $81.58 |
| Apr 24, 2026 | $81.97 |
| Apr 27, 2026 | $83.04 |
| Apr 28, 2026 | $82.68 |
| Apr 29, 2026 | $81.42 |
| Apr 30, 2026 | $88.46 |
| May 01, 2026 | $93.75 |
| May 04, 2026 | $94.68 |
| May 05, 2026 | $91.83 |
| 4 days before | -0.196% |
| 4 days after | 12.79% |
| On release day | 8.65% |
| Change in period | 12.56% |
Cimpress N.V Earnings Call Transcript Summary of Q1 2026
Cimpress (Vistaprint et al.) reported a strong start to FY2026 with consolidated Q1 revenue up 7% reported (4% organic constant currency). Growth was driven by Vistaprint and PrintBrothers, led by elevated products (promotional products, apparel, packaging/labels) which are increasing customer lifetime value. Cross‑Cimpress fulfillment (XCF) and MCP platform investments are enabling cost savings, faster product introductions, next‑day business card delivery, and greater intersegment fulfillment, while reducing unit costs. Adjusted EBITDA increased $10.9M YoY to the highest Q1 level on record, despite an ~80 bps gross margin contraction from product mix. Advertising intensity declined ~80 bps. Cash flow was seasonal negative (-$17.8M) due to working capital and higher planned CapEx/software capitalization. Net leverage was 3.1x EBITDA; liquidity remains strong (~$200M cash, $250M revolver undrawn). Management reiterated FY26 guidance: revenue growth 5–6% (2–3% organic CC), net income ≥ $72M, adjusted EBITDA ≥ $450M, operating cash flow ≈ $310M, adjusted free cash flow ≈ $140M, and a path to at least $600M adjusted EBITDA and significant deleveraging by FY28. Tariff impacts were minimal in Q1 (<$1M net), and management expects continued mitigation via pricing and supply chain actions. Management emphasized ongoing margin and efficiency opportunities from manufacturing consolidation, shared tech, organizational simplification and generative AI.
